# Randomized Double-Blind Clinical Trial of Rebamipide vs Esomeprazole in the Treatment of NSAID-induced Gastropathy

> **NCT00641004** · PHASE4 · COMPLETED · sponsor: **Otsuka Pharmaceutical, Inc., Philippines** · enrollment: 30 (estimated)

## Conditions studied

- NSAID Induced Gastropathy

## Interventions

- **DRUG:** Rebamipide and Esomeprazole

## Key facts

- **NCT ID:** NCT00641004
- **Lead sponsor:** Otsuka Pharmaceutical, Inc., Philippines
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-04
- **Primary completion:** 2010-03
- **Final completion:** 2010-03
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2011-08-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00641004

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00641004, "Randomized Double-Blind Clinical Trial of Rebamipide vs Esomeprazole in the Treatment of NSAID-induced Gastropathy". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00641004. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*